The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC

by palligoelme@gmail.com | Sep 15, 2025 | Clinical Trials

​ Conditions: Recurrent Cervical Cancer Interventions: Drug: RC48; Drug: QL1706 Sponsors: Qilu Hospital of Shandong University Not yet recruiting Conditions: Recurrent Cervical Cancer Interventions: Drug: RC48; Drug: QL1706 Sponsors: Qilu Hospital of Shandong...

Postprandial Glucose Handing in Contraceptive and IUD Users

by palligoelme@gmail.com | Sep 12, 2025 | Clinical Trials

​ Conditions: Glucose Homeostasis Interventions: Diagnostic Test: Oral Glucose Tolerance test (75g 2-hour) Sponsors: McMaster University Not yet recruiting Conditions: Glucose Homeostasis Interventions: Diagnostic Test: Oral Glucose Tolerance test (75g 2-hour)...

Automated Text Message Reminders to Promote Hearing Aid Adoption

by palligoelme@gmail.com | Sep 12, 2025 | Clinical Trials

​ Conditions: Hearing Loss Interventions: Behavioral: Automated text message reminder Sponsors: Stanford University Not yet recruiting Conditions: Hearing Loss Interventions: Behavioral: Automated text message reminder Sponsors: Stanford University Not yet...

The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density

by palligoelme@gmail.com | Sep 12, 2025 | Clinical Trials

​ Conditions: Chronic Kidney Disease Mineral and Bone Disorder Interventions: Other: Treat to target Sponsors: Herlev Hospital Not yet recruiting Conditions: Chronic Kidney Disease Mineral and Bone Disorder Interventions: Other: Treat to target Sponsors: Herlev...

An Active Health-Based Comprehensive Study on Diabetes Management

by palligoelme@gmail.com | Sep 12, 2025 | Clinical Trials

​ Conditions: Diabetes Interventions: Other: Digital Lifestyle Therapeutic; Behavioral: Standard Care Sponsors: Li Huating Recruiting Conditions: Diabetes Interventions: Other: Digital Lifestyle Therapeutic; Behavioral: Standard Care Sponsors: Li Huating...